Overview
Financials
Revenue history (in k)
Financial insight
- Estonian CIT: Equity includes non-zero Art. 28d line items – the company is taxed under the lump-sum regime on corporate income.
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 25 days late).
- 202510/06/2026
- 202404/06/2025
- 202322/06/2024
- 202201/06/2023
- 202109/08/2022
- 202010/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The President of the Management Board and the Vice-President, each of them independently, or two members of the management board jointly, or a member of the management board jointly with a commercial proxy, are authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Elżbieta Popiółage 54 | 25 | $675.31 | 50% |
Janusz Popiółage 62 | 25 | $675.31 | 50% |
Elżbieta Popiół and Janusz Popiół hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-02-29.
Bank spółdzielczy07 9081 0006 0000 1135 2000 0010
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $23,933.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,774$1,774 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,019$2,019 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 19, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $16,862$16,862 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o. | $16,601,428.28 | apimex.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Rutkiewicz I Wspólnicysp. j. | – | aptekapoznan.com |
FAQ
Last updated: 2026-06-10